Mengxin Geng

434 total citations
14 papers, 344 citations indexed

About

Mengxin Geng is a scholar working on Molecular Biology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Mengxin Geng has authored 14 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Pharmacology. Recurrent topics in Mengxin Geng's work include Microbial Natural Products and Biosynthesis (4 papers), Probiotics and Fermented Foods (3 papers) and Bacterial Identification and Susceptibility Testing (2 papers). Mengxin Geng is often cited by papers focused on Microbial Natural Products and Biosynthesis (4 papers), Probiotics and Fermented Foods (3 papers) and Bacterial Identification and Susceptibility Testing (2 papers). Mengxin Geng collaborates with scholars based in United States, China and Hong Kong. Mengxin Geng's co-authors include Liping Bai, Yu Jiang, Hong Yang, Leif Smith, Zhenghua Li, Jing Tan, Shengqin Lin, Xianglong Liu, Frank W. Austin and Steve W. Lockless and has published in prestigious journals such as Applied and Environmental Microbiology, Antimicrobial Agents and Chemotherapy and Applied Microbiology and Biotechnology.

In The Last Decade

Mengxin Geng

14 papers receiving 338 citations

Peers

Mengxin Geng
Mengxin Geng
Citations per year, relative to Mengxin Geng Mengxin Geng (= 1×) peers Chantal Fernandes

Countries citing papers authored by Mengxin Geng

Since Specialization
Citations

This map shows the geographic impact of Mengxin Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengxin Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengxin Geng more than expected).

Fields of papers citing papers by Mengxin Geng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengxin Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengxin Geng. The network helps show where Mengxin Geng may publish in the future.

Co-authorship network of co-authors of Mengxin Geng

This figure shows the co-authorship network connecting the top 25 collaborators of Mengxin Geng. A scholar is included among the top collaborators of Mengxin Geng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengxin Geng. Mengxin Geng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Min, J., et al.. (2022). Evaluation of analogs of mutacin 1140 in systemic and cutaneous methicillin-resistant Staphylococcus aureus infection models in mice. Frontiers in Microbiology. 13. 1067410–1067410. 4 indexed citations
2.
Geng, Mengxin, et al.. (2022). Synthesis and characterization of semisynthetic analogs of the antifungal occidiofungin. Frontiers in Microbiology. 13. 1056453–1056453. 3 indexed citations
3.
Geng, Mengxin, Limei Ai, Ming Ma, et al.. (2022). A DasA family sugar binding protein Ste2 links nutrient and oxidative stress to exopolysaccharides production in Streptomyces sp. 139. BMC Microbiology. 22(1). 69–69. 4 indexed citations
4.
Guo, Weiwei, et al.. (2022). [URA3 affects artemisinic acid production by an engineered Saccharomyces cerevisiae in pilot-scale fermentation].. PubMed. 38(2). 737–748. 3 indexed citations
5.
Jiang, Yu, Mengxin Geng, & Liping Bai. (2020). Targeting Biofilms Therapy: Current Research Strategies and Development Hurdles. Microorganisms. 8(8). 1222–1222. 131 indexed citations
6.
Ma, Jingbo, Zi‐Bing Jin, Mengxin Geng, et al.. (2020). Novel Antiparasitic Activity of the Antifungal Lead Occidiofungin. Antimicrobial Agents and Chemotherapy. 64(8). 13 indexed citations
7.
Ai, Limei, Mengxin Geng, Ming Ma, & Liping Bai. (2019). Complete Genome Sequence of the Ebosin-Producing Strain Streptomyces sp. 139. Microbiology Resource Announcements. 8(49). 2 indexed citations
8.
Geng, Mengxin, et al.. (2018). Efficacious Analogs of the Lantibiotic Mutacin 1140 against a Systemic Methicillin-Resistant Staphylococcus aureus Infection. Antimicrobial Agents and Chemotherapy. 62(12). 18 indexed citations
9.
Geng, Mengxin, Kenneth G. Hull, Jing Li, et al.. (2018). A Novel Actin Binding Drug withIn VivoEfficacy. Antimicrobial Agents and Chemotherapy. 63(1). 27 indexed citations
10.
Geng, Mengxin & Leif Smith. (2018). Modifying the Lantibiotic Mutacin 1140 for Increased Yield, Activity, and Stability. Applied and Environmental Microbiology. 84(15). 15 indexed citations
11.
Geng, Mengxin, et al.. (2017). Covalent Structure and Bioactivity of the Type AII Lantibiotic Salivaricin A2. Applied and Environmental Microbiology. 84(5). 22 indexed citations
12.
Geng, Mengxin & Leif Smith. (2017). Improving the attrition rate of Lanthipeptide discovery for commercial applications. Expert Opinion on Drug Discovery. 13(2). 155–167. 4 indexed citations
13.
Lin, Shengqin, Mengxin Geng, Xianglong Liu, Jing Tan, & Hong Yang. (2015). On the control of Microcystis aeruginosa and Synechococccus species using an algicidal bacterium, Stenotrophomonas F6, and its algicidal compounds cyclo-(Gly-Pro) and hydroquinone. Journal of Applied Phycology. 28(1). 345–355. 37 indexed citations
14.
Li, Zhenghua, Mengxin Geng, & Hong Yang. (2014). Algicidal activity of Bacillus sp. Lzh-5 and its algicidal compounds against Microcystis aeruginosa. Applied Microbiology and Biotechnology. 99(2). 981–990. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026